Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Shackleton

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The British Journal of Dermatology|December 9, 2025
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanomaPeinan Zhao, Christopher Chew, Pacman Szeto, et al.
Oncotarget|June 25, 2016
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcomeLih Yin Tan, Chris Mintoff, M Zahied Johan, et al.
Clinical and Translational Radiation Oncology|August 30, 2021
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous MelanomaWei Wang, Jessica Louise Smith, Matteo Salvatore Carlino, et al.
JAMA Dermatology|June 2, 2021
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz NeviSusan J Robertson, Lisa Orme, Rodrigo Teixeira, et al.
Cancer Research|June 22, 2016
CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to TumorigenicitySamantha E Boyle, Clare G Fedele, Vincent Corbin, et al.
Molecular Cancer Research : MCR|March 6, 2019
Somatic Hypermutation of the <i>YAP</i> Oncogene in a Human Cutaneous MelanomaXiaomeng Zhang, Jian Zhong Tang, Ismael A Vergara, et al.
Journal of Clinical Medicine|September 17, 2020
Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic MelanomaFiona A Lynch, Lynda Katona, Michael Jefford, et al.
Nature Medicine|July 24, 2012
MDM4 is a key therapeutic target in cutaneous melanomaAgnieszka Gembarska, Flavie Luciani, Clare Fedele, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Science Signaling|August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanomaRachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The British Journal of Dermatology|December 9, 2025
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanomaPeinan Zhao, Christopher Chew, Pacman Szeto, et al.
Oncotarget|June 25, 2016
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcomeLih Yin Tan, Chris Mintoff, M Zahied Johan, et al.
Clinical and Translational Radiation Oncology|August 30, 2021
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous MelanomaWei Wang, Jessica Louise Smith, Matteo Salvatore Carlino, et al.
JAMA Dermatology|June 2, 2021
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz NeviSusan J Robertson, Lisa Orme, Rodrigo Teixeira, et al.
Cancer Research|June 22, 2016
CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to TumorigenicitySamantha E Boyle, Clare G Fedele, Vincent Corbin, et al.
Molecular Cancer Research : MCR|March 6, 2019
Somatic Hypermutation of the <i>YAP</i> Oncogene in a Human Cutaneous MelanomaXiaomeng Zhang, Jian Zhong Tang, Ismael A Vergara, et al.
Journal of Clinical Medicine|September 17, 2020
Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic MelanomaFiona A Lynch, Lynda Katona, Michael Jefford, et al.
Nature Medicine|July 24, 2012
MDM4 is a key therapeutic target in cutaneous melanomaAgnieszka Gembarska, Flavie Luciani, Clare Fedele, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Science Signaling|August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanomaRachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Pageof 10